why choose us

First received: January 09, 2026

Clinical Trial: A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Kidney Failure
End-Stage Renal Disease
Renal Impairment

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Single-Dose Clinical Study to Evaluate the Pharmacokinetics of MK-2828 in Participants With Renal Impairment

Brief Summary: The goal of this trial is to measure what happens to 1 or 2 doses of MK-2828 in a person's body over time (pharmacokinetic or PK trial). Researchers want to learn if the PK of people with certain types of kidney disease is similar to the PK of healthy people.

Read more